Reduced circulating CD4+CD25+ cell populations in Guillain–Barré syndrome

[1]  R. Hughes,et al.  Guillain-Barré syndrome , 1994, The Lancet.

[2]  Y. Shinohara,et al.  Natural killer cells in patients with Guillain-Barré syndrome , 1998, Journal of the Neurological Sciences.

[3]  H. Wekerle,et al.  Morphologic study on experimental allergic neuritis mediated by T cell line specific for bovine P2 protein in Lewis rats. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[4]  M. Toda,et al.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. , 1998, International immunology.

[5]  J. Alcocer-Varela,et al.  Quantification of regulatory T cells in patients with systemic lupus erythematosus. , 2003, Journal of autoimmunity.

[6]  R. Hughes,et al.  The distribution of CD1 molecules in inflammatory neuropathy , 1998, Journal of the Neurological Sciences.

[7]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[8]  R. Hughes,et al.  A prospective study of acute idiopathic neuropathy. II. Antecedent events. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[9]  J. Ernerudh,et al.  T lymphocyte subset abnormalities in peripheral blood from patients with the Guillain-Barré syndrome , 1994, Journal of Neuroimmunology.

[10]  H. Hartung,et al.  Serum interleukin‐2 concentrations in Guillain‐Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: Comparison with other neurological diseases of presumed immunopathogenesis , 1991, Annals of neurology.

[11]  Nigel J. Saunders,et al.  CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms , 2003, The Journal of experimental medicine.

[12]  P. Krammer,et al.  Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis , 2005, European journal of immunology.

[13]  A. Fattorossi,et al.  Circulating and thymic CD4+ CD25+ T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment , 2005, Immunology.

[14]  H. Hartung,et al.  Inflammatory infiltrates in sural nerve biopsies in Guillain‐Barré syndrome and chronic inflammatory demyelinating neuropathy , 1996, Muscle & nerve.

[15]  W. Kuis,et al.  CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis , 2004, The Journal of Immunology.

[16]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[17]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[18]  D. Vergani,et al.  Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. , 2004, Journal of hepatology.

[19]  F. Yoshii,et al.  Impaired interleukin‐2 response of mononuclear cells in Guillain–Barré syndrome , 2000, European journal of neurology.

[20]  M. Honavar,et al.  A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review. , 1991, Brain : a journal of neurology.

[21]  H. Hartung,et al.  Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome , 1998, Annals of neurology.

[22]  S. Sakaguchi,et al.  Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation , 1996, The Journal of experimental medicine.

[23]  M. Roncarolo,et al.  Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function , 2001, The Journal of experimental medicine.

[24]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[25]  G. Mckhann,et al.  Differential Distribution of HLA-DQβ/DRβ Epitopes in the Two Forms of Guillain-Barré Syndrome, Acute Motor Axonal Neuropathy and Acute Inflammatory Demyelinating Polyneuropathy (AIDP): Identification of DQβ Epitopes Associated with Susceptibility to and Protection from AIDP1 , 2003, The Journal of Immunology.

[26]  S. Kremlev,et al.  Flow cytometric analysis of infiltrating cells in the peripheral nerves in experimental allergic neuritis , 2000, Journal of Neuroimmunology.

[27]  S. Cook,et al.  Clinical correlation with serum‐soluble interleukin‐2 receptor levels in Guillain‐Barré syndrome , 1991, Neurology.

[28]  G. Schuler,et al.  Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood , 2001, The Journal of experimental medicine.

[29]  R. Hughes,et al.  CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY , 1978, The Lancet.

[30]  R. Lechler,et al.  Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. , 2003, Kidney international.

[31]  H. Hartung,et al.  Expression and distribution of transcription factor NF-κB and inhibitor IκB in the inflamed peripheral nervous system , 2001, Journal of Neuroimmunology.

[32]  H. Hartung,et al.  T cell activation in Guillain‐Barré syndrome and in MS , 1990, Neurology.

[33]  R. Adams,et al.  The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. , 1969, Medicine.

[34]  R. Hughes,et al.  Guillain-Barré syndrome. , 1994, Lancet.

[35]  D. Cornblath,et al.  Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.

[36]  R. Hughes,et al.  T lymphocyte activation antigens in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy , 1989, Journal of Neuroimmunology.

[37]  A. Enk,et al.  Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood , 2001, The Journal of experimental medicine.

[38]  Svetlana Ten,et al.  Multiple immuno-regulatory defects in type-1 diabetes. , 2002, The Journal of clinical investigation.

[39]  D. Orlikowski,et al.  Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain–Barré syndrome and experimental autoimmune neuritis , 2003, Journal of Neuroimmunology.

[40]  J K Nicholson,et al.  Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. , 1996, Cytometry.

[41]  L. Klareskog,et al.  CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease , 2004, Arthritis research & therapy.

[42]  F. Yoshii,et al.  Lymphocyte Subset Proportions in Guillain-Barré Syndrome Patients Treated with Plasmapheresis , 2000, European Neurology.

[43]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.

[44]  H. Wekerle,et al.  A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. , 1984, Journal of immunology.

[45]  C. Brosnan,et al.  Phenotypic and functional properties of γδ T Cells from patients with Guillain Barré syndrome , 2000, Journal of Neuroimmunology.

[46]  Clare Baecher-Allan,et al.  MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells1 , 2006, The Journal of Immunology.

[47]  A. Scheffold,et al.  Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL‐)two to tango , 2005, European journal of immunology.

[48]  J. Malin,et al.  A longitudinal study of circulating lymphocyte subsets in the peripheral blood during the acute stage of Guillain-Barré syndrome , 1997, Journal of the Neurological Sciences.